Archive - NOETIK

GSK Licenses NOETIK’s OCTO-Virtual Cell Foundation Models to Transform Cancer Therapeutics R&D

We are announcing a five-year foundation model licensing partnership with GSK including $50M in upfront and near-term capital, and annual model…

Jan 8 • Ron Alfa

September 2025

How do you use a virtual cell to do something actually useful? (3/3)

Virtual perturbations that shift T cell effector state in humans

Sep 19, 2025 • Abhishaike Mahajan

How do you use a virtual cell to do something actually useful? (2/3)

Refining clinical trial eligibility to the right subgroups

Sep 12, 2025 • Abhishaike Mahajan

How do you use a virtual cell to do something actually useful? (1/3)

Identifying anti-PD1 responders

Sep 5, 2025 • Abhishaike Mahajan

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts